Casdin Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.33M Sell
100,000
-150,000
-60% -$4.99M 0.3% 25
2025
Q1
$7.33M Hold
250,000
0.6% 26
2024
Q4
$8.22M Buy
+250,000
New +$8.22M 0.55% 23
2022
Q3
Sell
-785,000
Closed -$17.4M 37
2022
Q2
$17.4M Sell
785,000
-1,305,000
-62% -$28.9M 1.47% 20
2022
Q1
$60.8M Hold
2,090,000
2.73% 15
2021
Q4
$68.7M Sell
2,090,000
-75,000
-3% -$2.47M 1.94% 16
2021
Q3
$99.9M Hold
2,165,000
2.49% 15
2021
Q2
$119M Hold
2,165,000
3.03% 12
2021
Q1
$112M Sell
2,165,000
-210,000
-9% -$10.8M 3.33% 10
2020
Q4
$103M Buy
2,375,000
+625,000
+36% +$27.1M 3.05% 10
2020
Q3
$61.3M Buy
1,750,000
+680,000
+64% +$23.8M 2.74% 10
2020
Q2
$57.2M Hold
1,070,000
3.39% 9
2020
Q1
$38M Buy
1,070,000
+245,000
+30% +$8.69M 4.03% 9
2019
Q4
$39.4M Sell
825,000
-110,000
-12% -$5.25M 3.62% 13
2019
Q3
$30.3M Buy
935,000
+440,000
+89% +$14.3M 3.14% 13
2019
Q2
$24.7M Buy
495,000
+160,000
+48% +$7.98M 2.31% 15
2019
Q1
$22.6M Sell
335,000
-110,000
-25% -$7.42M 2.48% 15
2018
Q4
$20.5M Sell
445,000
-134,776
-23% -$6.21M 3.51% 12
2018
Q3
$44.7M Buy
579,776
+215,000
+59% +$16.6M 5.43% 4
2018
Q2
$30.7M Hold
364,776
4.3% 8
2018
Q1
$29.8M Buy
364,776
+69,776
+24% +$5.71M 5.25% 6
2017
Q4
$16.9M Buy
295,000
+40,000
+16% +$2.29M 4.11% 11
2017
Q3
$17M Hold
255,000
4.81% 10
2017
Q2
$13.1M Buy
255,000
+17,500
+7% +$900K 4.85% 6
2017
Q1
$13.9M Sell
237,500
-3,000
-1% -$175K 8.18% 4
2016
Q4
$10M Sell
240,500
-41,943
-15% -$1.75M 8.29% 3
2016
Q3
$14.9M Buy
282,443
+94,943
+51% +$5.02M 12.08% 1
2016
Q2
$7.86M Buy
187,500
+39,500
+27% +$1.65M 7.82% 2
2016
Q1
$6.01M Buy
148,000
+51,500
+53% +$2.09M 6.9% 5
2015
Q4
$6.27M Buy
+96,500
New +$6.27M 5.54% 7